Surgical consultation and intervention during pediatric hematopoietic stem cell transplantation

Arin L Madenci1, Leslie E Lehmann, Christopher B Weldon

  • 1Department of Surgery, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA; Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Pediatric Transplantation
|September 17, 2014
PubMed

Insights

Children undergoing hematopoietic stem cell transplant (HSCT) frequently need surgical consultations, primarily for catheter issues. Surgical consults indicate a higher risk of mortality and transplant-related mortality in these pediatric patients.

Area of Science:

  • Pediatric surgery
  • Hematology
  • Oncology

Background:

  • Children undergoing hematopoietic stem cell transplant (HSCT) face risks from immune compromise, treatment toxicity, and indwelling catheters.
  • Surgical complications may necessitate evaluation by a surgical team during HSCT hospitalization.

Purpose of the Study:

  • To define the role and impact of surgical consultations during the primary hospital stay for pediatric HSCT.
  • To analyze the reasons for surgical consults and their association with patient outcomes.

Main Methods:

  • Retrospective review of consecutive pediatric patients undergoing HSCT between September 2010 and September 2012.
  • Analysis of general surgery consultation data, including reasons for consults and interventions performed.
  • Comparison of in-hospital mortality and 100-day transplant-related mortality (TRM) between patients with and without surgical consultations.

Main Results:

  • General surgery consultations occurred in 33% of HSCT hospitalizations, with 85 total consults across 189 HSCTs in 173 patients.
  • The majority of consults (59%) were for central venous line (CVL) issues, followed by abdominal complaints (16%).
  • Patients requiring surgical consultation showed significantly higher in-hospital mortality (16% vs. 2%) and 100-day TRM (10% vs. 2%) compared to those without consults.

Conclusions:

  • Surgical consultation is common during pediatric HSCT, predominantly for managing complications related to central venous lines.
  • The need for surgical consultation is associated with increased in-hospital mortality and 100-day TRM in pediatric HSCT recipients.
  • General surgeons and oncologists must be knowledgeable about the surgical issues encountered in this high-risk pediatric HSCT population.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.9K
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
913
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
3.7K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.4K
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.4K
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
815